Targeted Modulation of Matrix‐Remodeling: Enzymes, Adhesion Receptors, and Signaling Hubs as Precision Strategies for Antifibrotic Therapy
Year: 2026
Type: article
Abstract: ABSTRACT Liver fibrosis is increasingly recognized as a dynamic, spatially organized, and potentially reversible process of maladaptive wound healing rather than a passive consequence of collagen accumulation. Persistent liver injury activates multicellular fibrotic niches composed of hepatic stellate cells, macrophages, endothelial cells, fibrocytes, circulating myeloid populations, and extracellular matrix components that interact through reciprocal signaling networks. This review outlines a precision‐oriented antifibrotic framework centered on three interconnected target classes: matrix‐remodeling enzymes, adhesion receptors, and intracellular signaling hubs. Matrix metalloproteinases and tissue inhibitors of metalloproteinases regulate extracellular matrix turnover and determine whether fibrotic scars persist, remodel, or regress, indicating that productive fibrolysis should be restored rather than globally enhanced or suppressed. Adhesion receptors, particularly integrins, connect extracellular matrix composition and stiffness to intracellular mechanotransduction, latent TGF‐ β activation, hepatic stellate cell activation, and fibro‐inflammatory cell recruitment. Signaling hubs such as TGF‐ β \SMAD, GARP–TGF‐ β , FAK–RhoA/ROCK, PAK, NF‐ κ B, and YAP/TAZ integrate mechanical, inflammatory, and stromal cues into persistent profibrotic cellular states. Recent single‐cell, spatial transcriptomic, and spatial multi‐omics studies indicate that fibrosis is driven by disease‐specific cellular neighborhoods rather than uniform activation of single pathways or cell types. These findings support mechanism‐guided strategies that combine molecular target selection with spatial and temporal restriction to preserve physiological repair, immunity, regeneration, and tissue homeostasis. Future antifibrotic therapy will likely depend on identifying the dominant fibrotic niche in individual patients and selectively reprogramming the matrix, cell–matrix interface, and signaling networks that prevent fibrosis resolution.
DOI: 10.1002/ccs3.70124
Authors: Elke Roeb, Ralf Weiskirchen
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,860
OpenAlex ID: W7233605829
